Phthalates in plastics linked to 13 per cent of heart disease deaths in 2018 globally, finds study

New Delhi:  A recent study found that a daily exposure to phthalates, that is commonly used in making household plastic items, is linked to 3.5 lakh, or 13 per cent, deaths in the world due to heart disease in 2018, among people aged between 55 and 65 years of age. The study was published in the journal eBioMedicine and conducted by researchers from New York University.

According to the study, India has the highest death count at 103,587, followed by China and Indonesia. The study also found that about three-quarters of the 3.5 lakh deaths were borne by South Asia, along with the Middle East, East Asia and the Pacific, even as use of phthalates is widespread.

Researchers analysed health and environmental data from population surveys to estimate exposure to phthalates across 200 countries and territories. The study focused on a kind of phthalate called ‘di-2-ethylhexyl phthalate (DEHP)’ — used for making plastics in items, such as food containers, softer and more flexible.

Data, including those from urine samples, was analysed to discern amounts of products formed due to a chemical breakdown of the phthalate. Sara Hyman, an associate research scientist at New York University’s school of medicine and lead author of the study said, “By highlighting the connection between phthalates and a leading cause of death across the world, our findings add to the vast body of evidence that these chemicals present a tremendous danger to human health.”

The authors of the study said, “In 2018, an estimated 356,238 deaths globally were attributed to DEHP exposure, representing 13.497 per cent of all cardiovascular deaths among individuals aged 55-64.”

Phthalates have been shown to break down into microscopic particles and enter human bodies, increasing the risk of wide-ranging conditions, such as obesity, fertility issues and cancer. Exposure to this compound has been studied to trigger inflammation in the heart’s arteries, which, over time, is associated with increased risk of heart attack or stroke, the researchers said.

Findings from the analysis could help “inform ongoing negotiations of a Global Plastics Treaty”, they added. The United Nations (UN) Plastics Treaty is the world’s first legally binding treaty on plastic pollution.

The findings were found to align with global trends in plastics production and regulation, the team said.

For example, they said, India has a rapidly expanding plastics industry, and faces a substantial risk from exposure to phthalates due to plastic waste and extensive use of the item.

“There is a clear disparity in which parts of the world bear the brunt of heightened heart risks from phthalates,” senior author Leonardo Trasande, a professor of paediatrics at New York University’s school of medicine, said.

Related Posts

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Boehringer Ingelheim launches AI centre for pharma research in London

Boehringer Ingelheim launches AI centre for pharma research in London

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March